Skip to main content
. 2021 Sep 17;28(5):710–717. doi: 10.1016/j.cmi.2021.09.005

Table 2.

Participants who seroreverted compared to all other seropositive participants

Other seropositive Seroreverters p
N 2698 113
Female n (%) 1967 (72.9) 84 (74.3) 0.820
Age (mean ± SD) 39.43 ± 13.27 44.77 ± 12.80 <0.001
Body mass index (mean ± SD) 25.02 ± 4.71 24.48 ± 4.11 0.244
Ever smoker n (%) 370 (16.4) 23 (21.9) 0.177
Think they have had COVID-19 n (%) 1538 (84.6) 52 (54.7) <0.001
Severity of symptoms during COVID-19 n (%):a <0.001
 I had no symptoms 149 (9.7) 22 (42.3)
 I was at home with few/mild symptoms 405 (26.3) 12 (23.1)
 I was bedridden due to symptoms 949 (61.6) 18 (34.6)
 I was hospitalized due to symptoms 34 (2.2) 0 (0.0)
 I was hospitalized and on a respiratory support machine due to symptoms 4 (0.3) 0 (0.0)
a

Severity of illness only for participants who reported having been ill with COVID-19.